REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/08/2026
Back to search
Official data from USPTO
ASCENDIS PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ASCENDIS PHARMA
ST13
US500000087247108Class
42
Filing
87247108
Registration
5259688
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
08/08/2026
Trademark type
Word
Nice classes
42
Filing date
11/23/2016
Registration date
08/08/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/21/2023
Last transaction
08/08/2026
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Principal Register
First use anywhere
2009-12-00
First use in commerce
2009-12-00
Drawing code
4
Owner type
16
Owner location
Hellerup, DK
Examiner
BORSUK, ESTHER
Law office
L30
Current location
TMEG LAW OFFICE 103
Holders and representatives
Holders
Ascendis Pharma A/S
Representatives
Julianne Abelman Womble Bond Dickinson (US) LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Scientific research within the medicalpharmaceutical and bacteriological area; providing scientific consultancy and information in relation to the aforementioned scientific research; testing of pharmaceuticals; packaging designdesigning and development of medical equipment; developing pharmaceutical and medical preparations; design and development of pharmaceutical formulations; design and development of granulation technology and tablet technology; providing scientific consultancy and information relating to the design and development of granulation technology and tablet technology
Publications
History of USPTO decisions and trademark events.
20 publications found
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
11/21/2023
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
11/21/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/21/2023
ES8R
TEAS SECTION 8 RECEIVED
08/08/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/08/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
08/08/2017
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
07/05/2017
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
05/24/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/25/2017
PUBO
PUBLISHED FOR OPPOSITION
04/25/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/05/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/07/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
03/07/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/07/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
03/07/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/07/2017
DOCK
ASSIGNED TO EXAMINER
03/01/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/01/2016
NWAP
NEW APPLICATION ENTERED
11/26/2016
Continuous trademark protection
Get notified about every new filing that threatens ASCENDIS PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.